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Abstract
Background: Many policy makers and other stakeholders in the EU have expressed interest in better understanding
the performance of their own health systems to identify opportunities for improvement in effectiveness, efficiency and
equity. Health system performance assessment (HSPA) has received considerable attention at EU level as an instrument
to improve transparency and accountability. This is equally important for population health and sustainable health
spending. The goal of this paper is to synthesise and map the current state and developments in the field of HSPA
relevant in the EU context and by this aid the navigation in the growing HSPA system, understand the available tools
and identify opportunities for improvement.
Methods: Structured synthesis of the literature on initiatives in the field of HSPA at EU level was carried out. Key literature
was identified by a focused review performed between October 2015 and June 2016 on websites of key institutions
including the EU, OECD and WHO and Google engine. We used six predefined criteria for identifying key literature.
Identified initiatives were classified according to analytical and conceptual output or whether a guiding or advisory role
was resumed. A visual map of the relationships between the different actions and actors involved in HSPA was
developed. In addition, expert opinion was sought to refine the map.
Results: We identified a total of 64 relevant initiatives and their relationships in the field of HSPA. These include
institutions such as the European Commission (73%), European Council (8%), OECD (9%) and WHO-EUR (9%). 24
initiatives produced analytical outputs, four developed conceptual outputs and six had a guiding role. The role of the
EU in HSPA and collaboration with other key actors have intensified considerably since the adoption of the EU Health
Strategy in 2013. The EU HSPA landscape is complex with seemingly few streamlining activities.
Conclusions: Knowledge transfer and exchange of expertise are key to HSPA. While cooperation between the key actors
have intensified recently and clearly reflect the “Health in all Policies” (HIAP) approach, there is considerable room for
improved streamlining activities to share knowledge and avoid overlapping efforts, especially within the European
Commission.
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Background
Many policy makers, researchers, public health special-
ists and other stakeholders in the European Union (EU)
have expressed interest in better understanding the per-
formance of their health systems to identify opportun-
ities for improvement in effectiveness, efficiency and
equity. At the same time, health system performance as-
sessment (HSPA) at EU level has received considerable
attention as an instrument to improve transparency and
accountability.
According to Smith [1, 2] the prime objectives of
HSPA are:
 to set out the goals and priorities for a health
system;
 to act as a focus for policymaking and coordinating
actions within the health system;
 to measure progress towards achievement of goals;
 to act as a basis for comparison with other health
systems;
 to promote transparency and accountability to
citizens and other legitimate stakeholders for the
way that money has been spent.
While policy making in many areas of EU health sys-
tems is in the responsibility of Member States (MSs),
cross-country comparisons of health system performance
have become increasingly important. First, structural re-
form in many MSs and policy recommendations from the
European Commission have been increasingly targeting
health care. A large and growing share (30% in 2013) of
social protection spending in the EU is used for health
care services [3]. Second, the crisis including recent mi-
grant waves led to increased pressure on various segments
of social spending including health. Sustainability and effi-
ciency of health spending is thus high on the agenda. The
development of the directive aimed at making cross-
border health care for the EU citizens possible is seen as
another major driver behind the increased use of compari-
sons and benchmarking of quality of care provided [2, 4].
Also, the growing availability of comparable datasets has
enhanced the technical feasibility to compare performance
[2]. These data, carefully analysed and accompanied by
conceptual models of knowledge are powerful tools to in-
fluence policy-making [2, 5]. Finally, providing expertise
and assistance in the area of HSPA are a fundamental role
for the EU level, in setting standards, collating and dis-
seminating experience, and disseminating standardised in-
formation. Such endeavours are a public good that can
only be done effectively and comprehensively at EU level,
and can contribute new resources for guiding policy and
practice in individual MSs.
Health system performance is measured against mul-
tiple objectives. This calls for a strong framework covering
access, equity, efficiency and quality and their interrelation
in order to understand the content and the scope of the
comparison [2, 6]. Although HSPA is primarily a country-
specific process for which there is no single accepted
template, having harmonised methodologies and tools to
support health policy makers in taking decisions requires
actions also at EU level [1, 7]. The importance of good
practice HSPA therefore has been receiving high-level sup-
port both at national and at EU level [7, 8]. The European
Commission (EC) communication on effective, accessible
and resilient health systems [9] and the mandate from
November 2014 given to the European Commissioner for
Health by the EC President to develop expertise for HSPA
provide evidence of this support [10].
Progress has been made in monitoring the health of
the population and the performance of health systems in
terms of the scope, nature and timeliness of performance
data that have been made publicly available over the last
30 years [11]. Nevertheless, methodological challenges
remain in accomplishing the aim of health system gov-
ernance improvement. These challenges include creating
and unifying reporting standards of data and indicators,
and establishing coherent HSPA frameworks for cross-
country comparisons [12]. This should ultimately guide
the way how best to deploy performance data [11]. The
wider performance framework developed under the
EuroREACH project based on the OECD HCQI initia-
tive may be seen as one of the starting points in this
context [6].
Clear evidence is needed on the prioritization, including
the necessity and rationale for specific health system indi-
cators. Furthermore, core indicators for different types of
policy-use, (e.g. monitoring/forecasting, benchmarking,
target-setting, cross-country comparison) should be iden-
tified and categorised accordingly. In recent years, some
advanced cross-country approaches were established ana-
lysing the comparative performance of disease specific
variables across countries (EuroHOPE) [13] as well as
regional variations of hospital indicators (ECHO) [14].
However, there is a lack of a European-wide coherent
framework addressing data needs, quality of data and
guidance in using and applying indicators of HSPA.
While the Euro Health Consumer Index (EHCI), a pri-
vate initiative ranking 35 European health systems ac-
cording to their performance along 38 indicators shed
light on the potential of comparing important health
and health system indicators [15], it has been criticised
by some for the lack of transparency in indicator selec-
tion and scoring [16]. More work is needed in providing
standards for the quality of indicators and for a sound
rational of monitoring specific indicators and their signifi-
cance in cross-country comparisons. These challenges are
being addressed in BRIDGE Health, a European project
that aims at preparing a comprehensive, integrated and
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sustainable EU health information system which will in-
corporate know-how and technical tools to coordinate
and harmonise research and surveillance for MSs in key
EU health policy areas [17]. The present work forms an
integral part of BRIDGE Health research activities. In
addition, the BRIDGE Health System Indicator Task Force
was established to exchange expertise on the work of
health system performance indicators development.
Currently, stakeholders have difficulty navigating the
HSPA landscape, understanding the opportunities and
tools it provides, and using the data to identify opportun-
ities for improvement in effectiveness, efficiency and
equity of their healthcare systems. To the best of our
knowledge, no synthesis exists to help understand the
organization of the HSPA system at the EU level. Hence,
the goal of this paper is to synthesise the current state and
developments in the field of HSPA relevant to the EU con-
text by visually mapping the relationships between the dif-
ferent actions and actors involved in HSPA in the EU.
The rest of the paper is organised as follows. The second
part presents the methods, including six predefined selec-
tion criteria of initiatives and the output classification that
led to the structure of the visual map. Section 3 describes
the different initiatives that were identified both at EU and
joint action levels. Finally, the implications of the current
structure of HSPA in the EU are discussed.
Methods
Sources and initiative selection
A focused search was conducted and documented to
identify initiatives in health system performance at the
EU level. For simplicity, in this initial step we considered
initiatives that are either completely or mostly at EU
level covering the following key institutional players: the
European Commission and its relevant Directorates-
General (DG), EU agencies and the European Council,
the Organisation for Economic Cooperation and Devel-
opment (OECD), and the World Health Organisation
Regional Office Europe (WHO-EUR). Initiatives devel-
oped at the level of MSs and other international or inter-
governmental initiatives that do not pertain to Europe
(e.g. Commonwealth Fund, World Bank) were excluded.
Due to the nature of institutional websites as the pri-
mary source of this search and the inherent linkage
between findings, formal systematic review methods
were not pursued for the mapping exercise. The follow-
ing selection criteria for initiatives were applied of which
a minimum of three had to be fulfilled:
1. Initiatives that aim to harmonise monitoring of
health systems and health policy: initiative i) use
internationally comparative data, ii) are available
within the last 16 years, iii) have recurrent output
available in English language.
2. Initiatives that pertain to HSPA frameworks.
3. Initiatives that seek to foster transparency,
accountability and accessibility of data in the field of
public health and health systems research.
4. Initiatives that inform a blueprint for an indicator
repository of a European health information
infrastructure by referring to a list of indicators.
5. Initiatives that provide assessment of indicators and
meta-information related to the provision of i)
references on the indicator selection process, and ii)
description, calculation, rationale, data availability,
comparability of indicators.
6. Initiatives that provide analytical outputs for
evaluating health systems including a quantitative
analysis accompanied by an interpretation of
analytical outputs.
The current search was conducted on over 25 websites
of the key institutions, and the top 50 search hits of the
Google website. In addition, the database on completed
European and international projects drawn from the
Health Data Navigator (HDN) was used [18]. The HDN
was developed as part of the EuroREACH project and is
continued in BRIDGE Health. The search was limited to
a publication date after 2000 and was performed be-
tween October 2015 and June 2016 accompanied by
three rounds of adjustments based on input from ex-
perts of the BRIDGE Health System Indicators Task
Force. Included were policy and research documents,
consultation and opinion papers, project reports, meet-
ing minutes and other corresponding electronic docu-
ments. In total, over 75 websites were searched with the
following terms in English to draw out a broad range of
relevant initiatives: “health system performance assess-
ment” AND (“framework” OR “initiative” OR “method”)
AND (“EU” OR “European” OR “Europe” OR “European
Commission”). Tthe search string (“EU” OR “European”
OR “Europe” OR “European Commission”) was not used
on websites related to the EC and the European Council
to avoid redundancy. Reference lists of included litera-
ture were also examined. However, the majority of the
initiatives included in this synthesis were identified with
the search terms on the respective websites.
Synthesis
A visual organizational map was created which features
identified initiatives. Such a map is a commonly used
diagram in the field of business administration that out-
lines the roles, responsibilities and relationships between
individuals within an organization in just one picture
[19, 20]. It typically illustrates the relations and decision
making power by linking the different functions depicted
as boxes with lines on different levels [19, 20]. For our
purpose, the map was organised by institution and the
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extent of their contributions by making use of graphical
forms and colour schemes. The map makes use of angu-
lar rectangles to represent these institutions, their asso-
ciated key directorates the supporting agencies as well as
the individual initiatives. We further distinguished the
type of resources produced by these initiatives:
 Analytical output (yellow): provision of health data
series, indicators and/or any kind of analysis or
accompanied by respective country reports.
 Conceptual output (green): providing literature
review and/or conceptual innovation (e.g. suggesting
indicators, defining frameworks).
 Guiding or advisory, body (blue): mandated to create
recommendations and issue opinions on specific
topics related to health information and HSPA.
Initiatives for which more than one type of output ap-
plies are represented by multi-coloured rectangles
reflecting their multidimensionality. Lines indicate col-
laborative or supportive relations between actors and
initiatives. While there are of course links between Euro-
stat and OECD, the map expresses this collaboration via
the central role of the EC. A grey line connecting EC
and OECD is used to represent this increasingly import-
ant collaboration. This synthesis is complemented by a
timeline perspective in the form of a flow chart were the
evolvement of actors and actions between 1998 and
2016 in the field of HSPA is displayed.
Results
Figure 1 presents the current structure of HSPA initia-
tives and their respective organizational actors. The syn-
thesis of these initiatives resulted in a total of 64
activities indicated by different boxes. It consists of a
total of four key institutions aligned with six DGs in the
EC which are linked to seven supporting agencies. The
majority of displayed initiatives is associated with the EC
and the European Council amounting to 37 in total
when excluding the aforementioned EU institutional
players (N = 17). Five initiatives were included for both
the OECD and WHO-EUR. Concerning the type of out-
put, the map displays a total of 24 initiatives that were
classified as solely producing analytical outputs, four
with conceptual outputs and six with a guiding and/or
advisory role. Both analytical and conceptual outputs are
provided by a total of nine initiatives which are repre-
sented by multi-coloured rectangles in green and yellow.
A combination of conceptual output and guiding activ-
ities could be linked to a total of three initiatives illus-
trated by green and blue rectangles such as the “Peer
review on HSPA” initiative. In total eight initiatives in-
cluding the supporting agencieswere categorised to have
all three types of output. Figure 2 gives an overview of
the development process in the field of HSPA initiatives
over time indicating their relevant starting dates. Brief
narratives to the main findings are provided below.
International initiatives
International agencies play an important role in promot-
ing the comparison of health system performance across
EU countries [2]. Since the World Health Report 2000,
plenty of resources have been developed to facilitate
such comparison and support HSPA in general [1]. The
OECD and WHO have an instrumental role in driving
international comparisons of health systems with their
data repositories. The most important data are the OECD
Health Statistics including the “Health Care Quality Indi-
cators (HCQI)” [21–23] and the “WHO Health for All
database” [24], and specific annual publications, such as
“Health at a Glance” [25] or the “European Health Report”
[26, 27]. Furthermore, we identified different HSPA related
topics featured explicitly in publications resulting from the
OECD’s “health policy studies” [28–31]. Analytical work
on the efficiency of health care systems performed by Jou-
mard and colleagues remains central in this area [29].
More recently, the OECD initiated an “ad hoc reflection
group” to seek comments from experts on health care effi-
ciency indicators with the intent that comments would fa-
cilitate prioritization of these indicators [32].
Collaborative initiatives
A major milestone in the collaboration between the EC,
OECD and WHO-EUR was the initiation of the joint
data collection in the context of the OECD System of
Health Accounts (SHA), the standard framework for
producing consistent and internationally comparable
health system financial data [1, 33]. Also, the biannual
publication series “Health at a Glance: Europe” repre-
sents another major and vastly important collaboration
output between the EC and OECD.The selection of indi-
cators for this report is largely based on the “European
Core Health Indicators (ECHI)” shortlist. This list has
been created by the EC with the aim to monitor health
in the EU [34]. The “European Observatory of Health
Systems and Policies (OBS)” is a further partnership be-
tween the EC, the WHO-EUR, the World Bank and cer-
tain MSs serving as a prime source for informed and
comparable descriptions of health systems [35]. The
“European Health Information Initiative (EHII)”, estab-
lished in March 2015, is another recent collaboration be-
tween WHO-EUR, EC, OECD, MSs and related health
information networks and associations supporting the de-
velopment of a single European health information system
focusing on a set of targets and indicators as defined in
Health 2020 [36]. The “State of Health in the EU” initia-
tive, launched in June 2016, is the youngest collaborative
initiative with DG Santé and OECD which is aided by the
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OBS. Itt aims to develop individual country health profiles
to support health policies in EU countries [37].
EU initiatives
Main actors within the European Commission in the
field of HSPA are DG Santé, DG RTD, DG ECFIN, Euro-
stat, DG EAC and DG EMPL. The European Commis-
sion has created the “European Core Health Indicators
(ECHI)” initiative, which assembles 88 indicators rele-
vant to HSPA, for over 50 of which data are readily
available and reasonably comparable. Besides the ECHI
indicators and the joint “Health at a Glance: Europe” re-
ports, DG Santé operates the field of HSPA with further
initiatives. First, the “Expert Group on HSPA (EG
HSPA)” serves as a forum where MSs exchange experi-
ences on the use of HSPA at national level, and receive
Fig. 1 Existing HSPA initiatives at EU and at international level. Legend: AWG: Working Group on Ageing Populations and Sustainability; BBMRI:
Biobanking and Biomolecular Resources Research Infrastructure; CHAFEA: Consumer, Health and Food Executive Agency; COFOG: Classification of
the Functions of Government; CSR: Country Specific Recommendation; DG EAC: Directorate-General for Education and Culture; DG ECFIN:
Directorate-General for Economic and Financial Affairs; DG EMPL: Directorate-General for Employment, Social Affairs and Inclusion; DG RTD:
Directorate-General for Research & Innovation; DG SANTÉ: Directorate-General for Health and Food Safety; ECHI: European Core Health Indicators;
ECHO: European Collaboration for Health Optimization; EFSA: European Food Safety Authority; EGHI: Expert Group on Health Information; EHII:
European Health Information Initiative; EHIS: European Health Interview Survey; EHLEIS: European Health and Life Expectancy Information System;
EMA: European Medicines Agency; EMCDDA: European Monitoring Centre for Drugs and Drug Addiction; ENHIS: Environment and health 22
indicators system; ERIC: European Research Infrastructure Consortium; ESIF: European Structural and Investment Funds; ESS: European Social
Survey; ESSPROS: European system of integrated social protection statistics; EU-OSHA: European Agency for Safety and Health at Work;
EuroDRG: Diagnosis-Related Groups in Europe: towards Efficiency and Quality; EuroHOPE: European Health Care Outcomes, Performance and
Efficiency; EuroREACH: A Handbook to Access Health Care Data for Cross country Comparisons of Efficiency and Quality; SHARE: Survey of
Health, Ageing and Retirement in Europe; EU-SILC: European Union Statistics on Income and Living Conditions; EXPH: Expert Panel on Effective
Ways of Investing in Health; HCQI: Health Care Quality indicators; HFA: Health for All; HS: Health system; HSPA: Health System Performance
Assessment; ISG: Indicators’ sub-group; JAF: Joint Assessment Framework; MS: Member State; OECD: Organisation for Economic Co-operation
and Development; SDI: Sustainable Development Indicators; SHA: System of Health Accounts; SPC: Social Protection Committee; SSPM: Social
Protection Performance Monitor; Sub-group 5: Sub-group 5 on measuring and monitoring the effectiveness of health investments; WHO: World
Health Organisation; WPPHSL: Working Party on Public Health at Senior Level
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Fig. 2 Evolvement of actors and actions in the field of HSPA, EU initiatives in bold. Legend: BBMRI: Biobanking and Biomolecular Resources
Research Infrastructure; COFOG: Classification of the Functions of Government; CSR: Country Specific Recommendation; DG EAC: Directorate-
General for Education and Culture; DG ECFIN: Directorate-General for Economic and Financial Affairs; DG EMPL: Directorate-General for Employment,
Social Affairs and Inclusion; DG RTD: Directorate-General for Research & Innovation; DG SANTÉ: Directorate-General for Health and Food Safety; ECHI:
European Core Health Indicators; ECHO: European Collaboration for Health Optimization; EGHI: Expert Group on Health Information; EHIS: European
Health Interview Survey; EHLEIS: European Health and Life Expectancy Information System; ENHIS: Environment and health indicators system; ERIC:
European Research Infrastructure Consortium; ESIF: European Structural and Investment Funds; ESS: European Social Survey; EuroDRG: Diagnosis-
Related Groups in Europe: towards Efficiency and Quality; EuroHOPE: European Health Care Outcomes, Performance and Efficiency; EuroREACH: A
Handbook to Access Health Care Data for Cross country Comparisons of Efficiency and Quality; SHARE: Survey of Health, Ageing and Retirement in
Europe; EU-SILC: European Union Statistics on Income and Living Conditions; EXPH: Expert Panel on Effective Ways of Investing in Health; HCQI:
Health Care Quality indicators; HSPA: Health System Performance Assessment; JAF: Joint Assessment Framework; OECD: Organisation for Economic
Co-operation and Development; SDI: Sustainable Development Indicators; SHA: System of Health Accounts; SSPM: Social Protection Performance
Monitor; WHO: World Health Organisation;WPPHSL: Working Party on Public Health at Senior Level
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support in identifying tools and methodologies to de-
velop HSPA further [38]. So far, one relevant report has
been produced describing the different strategies MSs
apply to assess quality of care. Further work of the EG
HSPA will cover prioritised topics such as integrated
and primary care [39, 40]. Furthermore, the independent
and multidisciplinary “Expert Panel on Effective Ways of
Investing in Health (EXPH)” also issued an opinion on
identifying criteria for prioritizing areas for HSPA which
was based on work of the EG HSPA’s predecessor, called
“Sub-group 5 on measuring and monitoring the effect-
iveness of health investments” [12, 41]. The work of
Sub-group 5 was initiated by the Council’s “Working
Party on Public Health at Senior Level” in 2011. Most
recently, access to health services was also subject to a
detailed statement by the EXPH [42]. The “Expert
Group on Health Information (EGHI)”, a consultative
MSs body, supports the implementation of national and
cross-EU health strategies including health information
[43]. Core to this is the envisioned set-up of a European
Research Infrastructure Consortium (ERIC) on Health
Information which is currently being conceptualised
within the BRIDGE Health project [43–45]. Fig. 1 lists
most of the projects endowed by BRIDGE Health that
collected new data and developed health information
frameworks, standardisations and quality control
methods. The “European Structural and Investment
Funds ESIF for Health” developed a toolkit with a set of
widely available indicators deemed useful for the final
evaluation of actions supported from the ESIF [46].
Several other relevant projects have been funded
under the Commission’s FP7 programme to identify and
analyse health data from the perspective of cross-
country comparisons including “EuroREACH” [47],
“EuroHOPE” [13] and “ECHO” [48]. DG RTD funds EU
research programmes as part of Horizon2020 and the
Joint Research Centre (JRC). In the recent programme
JRC aims to provide science and knowledge service on
health and safe environment and consumer health and
safety among other non-nuclear topics [49]. In addition,
the “European Research Infrastructure Consortia
(ERICs)” “SHARE”, “BBMRI” and “ESS” were established
to provide resources and related services used by the sci-
entific community to conduct top-level research in the
broader field of health [50–53].
DG ECFIN has produced three relevant pieces of work
focusing on the sustainability of health services. For ex-
ample, in the context of the “European Semester”
Country-Specific Recommendations (CSR) are made
through the analysis of health system efficiency [54–57].
At EU level, the European Statistical Office, “Eurostat”,
is the main data collection body and main data provider
[58]. Its role in the area of high quality health data has en-
hanced greatly in recent years. In light of the broadened
understanding about the importance of wellbeing for eco-
nomic progress, the “Quality of life” indicators were devel-
oped [59]. Together with OECD’s “Better Life initiative”
[60] they form a further strand of approaches where rele-
vant indicators are being used. These initiatives are cur-
rently only loosely connected. At Eurostat level, the
initiative on “Sustainable Development Indicators” is using
selected health indicators at different levels of importance
for monitoring the sustainable development strategy of
the EU [61]. DG EAC monitors the health of Europe’s
youth with one tailored tool [62, 63].
Lastly, the “Social Protection Committee (SPC)” and
its Indicators Subgroup adapted the “Joint Assessment
Framework (JAF)” methodology to the area of health
systems. This serves as a reference HSPA tool for sup-
porting the monitoring and assessment of structural re-
forms focusing on issues related to access, quality and
equity [5, 8]. Progress on the social protection policy
goals is monitored with a tool called “Social Protection
Performance Monitor (SPPM)” that makes use of some
specific ECHI indicators [64]. The recent “European Pil-
lar of Social Rights” initiative led by DG EMPL also ad-
dresses the importance of timely access to ensure good
quality and affordable health care and long-term care for
Europeans [3].
Discussion
This paper focused on synthesising and visualizing major
HSPA activities and actions in the EU context initiated
before and ongoing in June 2016. This synthesis is com-
plemented by a timeline perspective. Fig. 2 gives an
overview of the development process in the field of
HSPA initiatives. It shows that activities in this area have
intensified in recent years including enhanced efforts to
better collaborate across key international actors. The
results of this synthesis paper highlight three main
points within the sphere of HSPA in the EU.
First, there is a clear reflection of the “Health in all
Policies” (HIAP) approach [65] emphasised in the Com-
mission’s Communication in 2014 on health systems and
a growing visibility of HSPA as shown in the timeline
perspective [9]. The Commission promotes cooperation
at EU level with a view to strengthen effectiveness, in-
crease accessibility and improve resilience of the national
health systems in the EU. Many DGs have activities in
place to promote HSPA, such as the provision of com-
parable indicators to monitor health and health systems
(ECHI), expert bodies for better exchange of experiences
between MSs (e.g. EG HSPA) or structured HSPA
frameworks to guide monitoring (JAF Health). These ac-
tions are complemented by co-funded research in this
area [44].
Second, the map reflects the complexity of coordinat-
ing recent activities in HSPA. Different roles assumed by
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individual DGs and their relationships between each
other within the field of HSPA are not entirely clear at
this stage. For example, while DG Santé is mainly con-
cerned with population health and health information is-
sues in general, DG EMPL has a focus on access to
health care including equity issues, and DG ECFIN con-
centrates on efficiency and sustainability. While this
fragmentation between DGs largely reflects policy man-
dates under current EU governance responsibilities, it
calls for improved cooperation across them to better
bundle expertise on the different domains covered by
HSPA. Also and as Fig. 2 indicates, HSPA only gained
formal attention in 2013 with the adoption of the EU
Health Strategy “Together for Health” [66]. Even though
the Commission managed to considerably increase the
visibility of the role of the EU in HSPA since then, the
visualisation of the current activities suggests that coord-
ination needs improvement. For example, to achieve the
goals outlined in key documents on health systems 2014
regarding e.g. resilience and sustainability likely requires
more capacities across Commission services [9, 10]. In-
creasing cooperation within the Commission would re-
duce duplications of work and ensure more inclusivity.
Third, the current mapping exercise should be seen as
a starting point for extension to MS-level HSPA initia-
tives and potential other relevant international initiatives
to build the base for the development of a comprehen-
sive indicator repository. Such initiatives will be included
in the planned next wave of our HSPA research in the
context of BRIDGE Health activities. The work will
focus on a comprehensive synthesis of the relevant indi-
cator landscape. Starting point is the development of the
european Health System Indicators survey (euHS_I sur-
vey). The euHS_I survey aims to identify overlaps be-
tween these initiatives and gaps in the relevant
availability of health care system performance indicators.
Also, the importance of indicators for the different per-
formance domains will be assessed. This should lead to
the compilation of a set of high quality headline indica-
tors with important policy relevance for HSPA.
The synthesis provided within this paper has limita-
tions. First, it focuses on major players and excludes
MS initiatives as well as other potentially relevant
international initiatives (e.g. World Bank, EHCI, Com-
monwealth Fund). Second, the visual map shows the
status quo in 2016 including also bodies that were re-
placed by newly created Expert groups such as the
Sub-group 5 from the WPPHSL paving the way to
the creation of the EG HSPA. Figure 2 was created to
complement the map with a timeline. However, com-
munication/collaboration lines between different DGs
were omitted for simplification purposes. For ex-
ample, there is cooperation and exchange between EG
on HSPA with EGHI and SPC/ISG. Not displaying
those lines should not create the impression that
there is no collaboration or interaction at all.
Conclusions
This paper synthesises, maps and describes the current
developments in HSPA at EU level. To our knowledge,
this is the first piece of work to map out the relation-
ships between different actors and actions driving the
field of HSPA.
The results of this mapping exercise can be used to
obtain a comprehensive overview of the current develop-
ments in the field of HSPA. In summary, our findings in-
dicate that the European Commission’s role in HSPA is
increasingly important to promote standards for good
practice HSPA. Also, activities are largely consistent with
goals outlined with the adoption of the EU Health Strat-
egy in 2013. This reflects the strengthened role of the
European Commission as a hub for promoting unified
standards to enhance comparative analysis of welfare
systems. Equally, it acknowledges the increasing import-
ance of health system performance for European policy
making. However, the coordination of various HSPA ac-
tivities by different actors, especially within the Euro-
pean Commission leaves room for improved cooperation
in order to avoid duplication of work and ensure overall
efficiency of ongoing activities.
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